Saturday October 13 is one year since the first clinic opened in the PrEP Impact trial (13 October 2017), a three-year trial which aimed to provide the HIV prevention drug PrEP to 10,000 people. The number of places on the trial was determined on the basis of anticipated demand but this number proved to be a sizeable underestimate. By the end of March 2018 22 clinics had filled all their allocated places for gay and bisexual men. As a result men in need of PrEP were being turned away.

• 32 organisations demand HIV prevention drug PrEP to be routinely available on the NHS by 1 April 2019

• The current three-year trial will provide PrEP to 10,000 people – but more than 7,000 places have been taken in less than a year

Today the Mayor of London, London Councils, Public Health England and NHS England signed a historic pledge to join the Fast-Track Cities initiative – part of a global effort to reduce HIV and HIV stigma.